IJGC conversations

Molecular Targets in Endometrial Cancer: Real World Outcomes (ECMT2) with Angeles Alvarez Secord

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr Angeles Alvarez Secord to discuss Molecular Targets in Endometrial Cancer: Real World Outcomes (ECMT2).
Angeles Alvarez Secord, MD, MHSc, is a professor in the Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Duke University Heath System. She received her undergraduate degree with honors from Carroll College in Helena, Montana and graduated AOA with honors from the University of Washington School of Medicine in Seattle, Washington. Dr. Secord completed her residency in obstetrics and gynecology and her fellowship in gynecologic oncology at the Duke University Medical Center in Durham, North Carolina. Upon completing her fellowship in 2001, she joined the Division of Gynecologic Oncology at Duke. She is currently Director of Gynecologic Oncology Clinical Trials, Associate Director of Clinical Research, Gynecology Oncology, and one of the Principal Investigators for NRG Oncology at the Duke Cancer Institute. Dr. Secord serves on the GOG Foundation Board of Directors. She is passionate about mentoring the next generation of investigators and serves as the GOG Foundation Education and Mentoring Chair and the NRG Oncology Investigator and Career Development Committee Vice-Chair. Dr. Secord is a fellow of the American College of Obstetricians and Gynecologists and an active member of American Society of Clinical Oncology, American Gynecological & Obstetrical Society, Society of Gynecology & Oncology, and International Gynecologic Cancer Society as well as other professional organizations.

IJGC conversations 2025 April Editor's Choice

In this episode of the IJGC conversations 2025 April Editor's Choice, Editorial Fellow Stephanie Gill and Elise Mann Yates discusses the contents of the 2025 April issue of IJGC. 

Real-word PARPi Maintenance and Recurrence Patterns with Anna Fagotti and Matteo Loverro

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Matteo Loverro and Anna Fagotti to discuss Real-word PARPi Maintenance and Recurrence Patterns.
Anna Fagotti is a Professor and Consultant of Gynecologic Oncology at A. Gemelli University Hospital Foundation IRCCS. She is the President of ESGO - European Society of Gynaecological Oncology. Her research interests are Obstetrics and Gynecology, Gynecologic Oncology, Advanced Ovarian Cancer, Gynecological Cancer, and Laparoscopic Surgery.
Matteo Loverro is an ESGO fellow at Fondazione Policlinico Universitario A. Gemelli, IRCCS @unicatt. 

Substantial LVSI and Recurrence in Endometrial Cancer with Nadeem Abu-Rustum and Christian Dagher

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Nadeem Abu-Rustum and Christian Dagher to discuss Substantial LVSI and Recurrence in Endometrial Cancer.
Dr. Abu-Rustum is a board-certified gynecologic oncologist who specializes in the surgical treatment of gynecologic cancers at Memorial Sloan Kettering Cancer Center. He is also a professor of obstetrics and gynecology at Weill Cornell Medical College. Dr. Abu-Rustum has a special interest in minimally invasive surgery (laparoscopy) for the treatment of cancerous and noncancerous diseases of the female reproductive system, and his clinical research focuses on surgical therapy for gynecologic cancers and innovative surgical approaches to treating gynecologic disorders.
Christian Dagher is a former research fellow at Memorial Sloan Kettering, and current OBGYN resident at the University of Pennsylvania. He holds a master's degree in clinical epidemiology and health-services research from Weill-Cornel. Before moving to the US, he completed an OBGYN residency at the American University of Beirut and is interested in studying survival biomarkers in endometrial cancer. 

Surgery for Stage IV Ovarian Cancer with Floriane Jochum

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Floriane Jochum to discuss Surgery for Stage IV Ovarian Cancer.
Dr. Floriane Jochum is a Gynecologic Oncologist at Strasbourg University Hospital in France. She recently completed her PhD in cancer research and computational epidemiology at Institut Curie in Paris. Her doctoral work focused on the multiple applications of real-world data in gynecologic oncology, exploring topics ranging from disparities in access to care to the development of emulated clinical trials. 

Rare gynecologic cancers with IJGC fellows

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by the IJGC editorial fellows to discuss the IJGC Special Issue on Rare gynecologic cancers. 

QoL Assessment on SHAPE Trial with Sarah E. Ferguson

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Sarah E. Ferguson to discuss QoL Assessment on SHAPE Trial.
Dr. Sarah Ferguson is a Gynecologic Oncologist at Princess Margaret Cancer Centre (University Health Network), a Professor and Vice Chair of Research in the Department of Obstetrics and Gynecology at the University of Toronto, and an Associate Scientist at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital. Dr. Ferguson is currently the Head of Research for the Department of Obstetrics and Gynecology for Mount Sinai Hospital/University Health Network. Her clinical and research interests include: improving surgical techniques and patient outcomes, survivorship and supportive care as well as hereditary cancer syndromes in gynecology, in particular Lynch syndrome.

De-escalation in Gynecologic Oncology with Núria Agustí

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Núria Agustí to discuss De-escalation in Gynecologic Oncology. Dr. Agustí specializes in gynecologic oncology at Hospital Clinic of Barcelona. She is currently a PhD researcher at the University of Barcelona and engaged in a postdoctoral fellowship at MD Anderson Cancer Center, USA. She recently completed the IJGC Editorial Fellowship program

IJGC conversations 2025 February Editor's Choice

In this episode of the IJGC conversations 2025 February Editor's Choice, Editorial Fellow Matteo Marchetti and Thomas Bartl discusses the contents of the 2025 February issue of IJGC. 

LANCE Trial: Results of Feasibility Phase with Jose Alejandro Rauh-Hain

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jose Alejandro Rauh-Hain to discuss LANCE Trial: Results of Feasibility Phase.
Dr. Rauh-Hain is a Gynecologic Oncologist at the University of Texas MD Anderson Cancer Center. Born in Mexico City, he earned his medical degree from Universidad Panamericana and completed a research fellowship at Massachusetts General Hospital, focusing on preeclampsia biomarkers. He trained in Obstetrics and Gynecology at Massachusetts General and Brigham and Women's Hospital, followed by a Gynecologic Oncology fellowship at Harvard Medical School. He also holds an MPH from Harvard and completed a post-doctoral fellowship in Cancer Outcomes Research. His interests include gynecologic cancer surgery, rare tumor management, and research on reducing disparities in cancer care.